Citations

Clear

1446 citation(s) found for "Howard, F".

Workshop on imaging science development for cancer prevention and preemption
Kelloff, Gary J. , Sullivan, Daniel C. , Baker, Houston, Clarke, Lawrence, Nordstrom, Robert J. , Tatum, James L. , Dorfman, Gary S., Berg, Christine D. , Birrer, Michael J. , Tempero, Margaret A. , Higley, Howard R., Petty, Brenda Gumbs, Sigman, Caroline C. , Ginsberg, Gregory G. , Dannenberg, Andrew J. , Hawk, Ernest T. , Messing, Edward M. , Grossman, H. Barton, Griebel, Donna, Henson, Donald E., Fabian, Carol J. , Zujewski, Jo Anne , Hayes, Wendy, Klein, Eric A. , Ocak, İclal , Tempany, Clare M. , Shtern, Faina, Parnes, Howard L. , Gómez, Jorge , Srivastava, Sudhir , Lam, Stephen , Seibel, Eric J. , Massion, Pierre P. , McLennan, Geoffrey, Burt, Randall W., Hoffman, John M. , El‐Deiry, Wafik S. , Papadimitrakopoulou, Vali, Veltri, Robert W., Solomon, Diane, Viner, Jaye L., Stratton, Steven P. , Rajadhyaksha, Milind , Dhawan, Atam P. , Jacobs, Paula , Pomper, Martin G. , Maley, Carlo C. , Sharma, Prateek , Wax, Adam , Harisinghani, Mukesh G. , Bigio, Irving J. , Ferrara, Katherine W. , Fantini, Sergio , Schnall, Mitchell D. , Zujewski, Jo Anne , Marzo, Angelo M. De , Ketterling, Jeffrey A. , Szabó, Éva , Cleary, Kevin , Suh, Robert D. , Pfeiffer, Ruth M. , Roy, Hemant K. , Wang, Thomas J. , Limburg, Paul J. , Hittelman, Walter N. , MacAulay, Calum E. , Jerónimo, José , Richards‐Kortum, Rebecca , Johnson, Karen A. , Klein, Eric A

Mayo Clinic

Cancer Biomarkers | January 31, 2017 | Volume: 3 | Issue: 1 | Pages: 1-33

10.3233/cbm-2007-3101 | PMID 17655039 Get It

Management and Outcomes of ST-Segment Elevation Myocardial Infarction in US Renal Transplant Recipients
Khera, Sahil , Aronow, Wilbert S. , Cooper, Howard A., Rihal, Charanjit S. , Panza, Julio A. , Bhatt, Deepak L. , Gupta, Tanush , Kolte, Dhaval , Goel, Kashish , Jain, Diwakar , Rihal, Charanjit S. , Fonarow, Gregg C. , Bhatt, Deepak L

Mayo Clinic

JAMA Cardiology | January 18, 2017 | Volume: 2 | Issue: 3 | Pages: 250

10.1001/jamacardio.2016.5131 | PMID 28097322 Get It

Treating Tobacco Use and Dependence in Kidney Transplant Recipients: Development and Implementation of a Program
Ehlers, Shawna L. , Patton, Pamela R., Lloyd-Turner, Joni, Howard, Richard J. , Rodrigue, James R. , Kaplan, Bruce

Mayo Clinic

Progress in Transplantation | January 13, 2017 | Volume: 16 | Issue: 1 | Pages: 33-37

10.1177/152692480601600108 | PMID 16676672 Get It

Tobacco use adversely affects transplant outcomes such as graft survival, patient survival, and other conditions that alter transplant patient longevity. Especially concerning is tobacco's relationship to cardiovascular disease, the number 1 cause of death in kidney transplant recipients. Many authors conclude that tobacco interventions ought to be provided to patients and sometimes lament that there are no tobacco dependence interventions designed for kidney transplant recipients. European Best Practice Guidelines for Renal Transplantation also support tobacco dependence interventions. The purpose of this article is to describe one institution's experience in implementing the clinical practice guideline for treating tobacco use and dependence within a kidney and pancreas transplant program.
Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study
Feng, Tom , Howard, Lauren E. , Vidal, Adriana C. , Moreira, Daniel M. , Castro‐Santamaria, Ramiro , Andriole, Gerald L. , Freedland, Stephen J. , Vidal, Adriana C. , Howard, Lauren E

Mayo Clinic

International Journal of Urology | December 22, 2016 | Volume: 24 | Issue: 2 | Pages: 151-156

10.1111/iju.13265 | PMID 28004415 Get It

ObjectiveTo determine if cholesterol is a risk factor for the development of lower urinary tract symptoms in asymptomatic men.MethodsA post‐hoc analysis of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study was carried out in 2323 men with baseline International Prostate Symptom Score <8 and not taking benign prostatic hyperplasia or cholesterol medications. Cox proportion models were used to test the association between cholesterol, high‐density lipoprotein, low‐density lipoprotein and the cholesterol : high‐density lipoprotein ratio with incident lower urinary tract symptoms, defined as first report of medical treatment, surgery or two reports of an International Prostate Symptom Score >14.ResultsA total of 253 men (10.9%) developed incident lower urinary tract symptoms. On crude analysis, higher high‐density lipoprotein was associated with a decreased lower urinary tract symptoms risk (hazard ratio 0.89, P = 0.024), whereas total cholesterol and low‐density lipoprotein showed no association. After multivariable adjustment, the association between high‐density lipoprotein and incident lower urinary tract symptoms remained significant (hazard ratio 0.89, P = 0.044), whereas no association was observed for low‐density lipoprotein (P = 0.611). There was a trend for higher cholesterol to be linked with higher lower urinary tract symptoms risk, though this was not statistically significant (hazard ratio 1.04, P = 0.054). A higher cholesterol : high‐density lipoprotein ratio was associated with increased lower urinary tract symptoms risk on crude (hazard ratio 1.11, P = 0.016) and adjusted models (hazard ratio 1.12, P = 0.012).ConclusionsAmong asymptomatic men participating in the REDUCE study, higher cholesterol was associated with increased incident lower urinary tract symptoms risk, though the association was not significant. A higher cholesterol : high‐density lipoprotein ratio was associated with increased incident lower urinary tract symptoms, whereas higher high‐density lipoprotein was protective. These findings suggest dyslipidemia might play a role in lower urinary tract symptoms progression.
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation
Snyder, Heather M. , Ahles, Tim A. , Calderwood, Stuart K. , Carrillo, María C. , Chen, Honglei , Craft, Suzanne , Jager, Philip L. De , Driver, Jane A. , Fillit, Howard , Tierney, Mary C. , Petanceska, Suzana, Saykin, Andrew J. , Seshadri, Sudha , Shineman, Diana W., Chang, Chung-Chou H. , Knopman, David S. , Lotze, Michael T. , Ganguli, Mary , Saykin, Andrew J , Seshadri, Sudha , Snyder, Heather M

Mayo Clinic

Alzheimer's & Dementia | December 18, 2016 | Volume: 13 | Issue: 3 | Pages: 267-273

10.1016/j.jalz.2016.11.002 | PMID 27998721 Get It

AbstractRecent population studies suggest an intriguing inverse relationship between several types of cancer and neurodegenerative diseases, including Alzheimer's disease. Understanding the intersection of the underlying biology for these two distinct families of diseases with one another may offer novel approaches to identify new therapeutic approaches and possible opportunities to repurpose existing drug candidates. The Alzheimer's Association and the Alzheimer's Drug Discovery Foundation convened a one‐day workshop to delve into this discussion. Workshop participants outlined research focus areas, potential collaborations, and partnerships for future action.
Everyday Support to Aging Parents: Links to Middle-Aged Children’s Diurnal Cortisol and Daily Mood
Bangerter, Lauren R. , Liu, Yin , Kim, Kyungmin , Birditt, Kira S. , Fingerman, Karen L. , Zarit, Steven Howard , Kim, Kyungmin

Mayo Clinic

The Gerontologist | November 22, 2016 | Volume: 58 | Issue: 4 | Pages: 654-662

10.1093/geront/gnw207 | PMID 28073999 Get It

Abstract Purpose of the Study Middle-aged adults are often called upon to support aging parents. However, providing support to an aging parent with health problems and disability may be a stressful experience. This study asked whether giving everyday support to parents in the context of health problems and disability has implications for middle-aged children’s diurnal cortisol and daily mood. Design and Methods During four consecutive days, 148 middle-aged adults (mean age = 55) reported the support they gave to their parents and provided saliva 4 times a day (wake, 30 min post-wake, lunchtime, and bedtime). Multilevel models estimated within-person differences in positive affect (PA) and negative affect (NA), cortisol awakening response and area under the curve with respect to ground (AUC-G) as a function of giving same-day and previous-day support. We examined whether these associations are exacerbated when a parent has health problems or activities of daily living (ADL) needs. Results Middle-aged children had significantly higher next-day AUC-G on days after they gave support to parents with ADL needs. When participants gave support to parents with ADL needs, they had significantly greater same-day PA and lower next-day NA. Giving support to parents with health problems was associated with significantly higher next-day NA. Implications Giving support to parents is an ambiguous experience with implications for biological stress and daily mood. A biopsychosocial approach reveals under what conditions giving support to parents may become detrimental to health and well-being; this knowledge is essential for the development and implementation of interventions.
Incidental EBV-positivity in paediatric post-transplant specimens demonstrates the need for stringent criteria for diagnosing post-transplant lymphoproliferative disorders
King, Rebecca L. , Paessler, Michele, Howard, Matthew T., Wertheim, Gerald

Mayo Clinic

Journal of Clinical Pathology | November 16, 2016 | Volume: 70 | Issue: 3 | Pages: 270-273

10.1136/jclinpath-2016-203924 | PMID 27852687 Get It

Aims To examine the need for minimal diagnostic criteria for post-transplant lymphoproliferative disorders (PTLD) in children, we sought to determine the rate of incidental Epstein-Barr virus (EBV)-positivity in tissues from organ transplant recipients (OTR). Methods EBV in situ hybridisation (ISH) was done retrospectively on tissue from 34 paediatric autopsies of OTR and paediatric tonsillectomy specimens from non-OTR (96) and OTR (6). Patients with a history of PTLD were excluded from both data sets. Results EBV-positivity was found incidentally in 2/34 autopsy cases (5.9%). Median time from transplant to death for all patients was 12.8 months (range 0.1–153 months). Median time between transplant and death in EBV-positive cases was 34 months. EBV was positive in 26/102 tonsils (25%). Among tonsils from OTR, 4/6 (67%) were EBV-positive. Conclusions These findings reinforce the need for strict morphological and clinical criteria, other than EBV-positivity, when diagnosing PTLD in the paediatric population.
Willingness to Be a Brain Donor
Boise, Linda, Hinton, Ladson , Rosen, Howard J. , Ruhl, Mary C., Albert, Marilyn , Denny, Andrea, Hughes, Travonia, Lingler, Jennifer H. , Morhardt, Darby, Parfitt, Francine, Peterson-Hazan, Susan, Pop, Viorela, Rose, Tara , Shah, Raj C. , Hinton, Ladson , Dodge, Hiroko Hayama , Mattek, Nora , Grill, Joshua D. , Shah, Raj C

Mayo Clinic

Alzheimer Disease & Associated Disorders | October 25, 2016 | Volume: 31 | Issue: 2 | Pages: 135-140

10.1097/wad.0000000000000174 | PMID 27779492 Get It

Introduction: Racial and ethnic groups are under-represented among research subjects who assent to brain donation in Alzheimer disease research studies. There has been little research on this important topic. Although there are some studies that have investigated the barriers to brain donation among African American study volunteers, there is no known research on the factors that influence whether or not Asians or Latinos are willing to donate their brains for research. Methods: African American, Caucasian, Asian, and Latino research volunteers were surveyed at 15 Alzheimer Disease Centers to identify predictors of willingness to assent to brain donation. Results: Positive predictors included older age, Latino ethnicity, understanding of how the brain is used by researchers, and understanding of what participants need to do to ensure that their brain will be donated. Negative predictors included African/African American race, belief that the body should remain whole at burial, and concern that researchers might not be respectful of the body during autopsy. Discussion: The predictive factors identified in this study may be useful for researchers seeking to increase participation of diverse ethnic groups in brain donation.